Kevin Nicholson, our CEO, and Belinda Brokke, Clinical Administrator, featured in an article on ketamine therapy.

Kevin Nicholson talks ketamine safety and the unprecedented benefits of infusion therapy.

Congress is warming up to psychedelics, especially when it comes to PTSD treatment. “I love the fact that there’s more interest, there’s more conversations, and we can ultimately help more people,” says KWC CEO Kevin Nicholson.

KWC CEO Kevin Nicholson on the benefits of ketamine therapy and his journey through the medical field.

The U.S. Department of Veterans Affairs has launched clinical trials to study the effectiveness of psychedelic drugs including MDMA and psilocybin as a treatment for military veterans with post-traumatic stress disorder, addiction and other…

With prior authorization from the VA, veterans will have the possibility to undergo therapy at KWC Arizona clinics in Phoenix, Tucson and Mesa-Gilbert at no out-of-pocket cost.

Ketamine Wellness Centers announced the introduction of NAD+ infusion therapy at six of its clinic locations.

Delic Holdings Corp.’s DELCF subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.

Interest is rising in the idea that ketamine, typically used as an anaesthetic (or as an illegal party drug), can help provide a lasting cure where traditional treatments, such as antidepressant drugs, have failed.

An interview with CEO Kevin Nicholson.